EV Manufacturing & Testing (MIT collaboration)
Type: Forecast
Overview
Description
Dedicated funding for specialized isolation kits, reagents, and materials to support our active, ongoing collaboration with MIT. This is essential for developing robust Extracellular Vesicle (EV) manufacturing and testing strategies.
Est. Value
Min: $25,000
Max: $250,000
Max: $250,000
Est. Award Date
27-Sep
Future Opp
Source Est. Solicitation Date
27-May
Set Aside
To be determined
Place of Performance
USA
Forecast Source
Department of Health and Human Services
Food and Drug Administration is forecasted to issue a procurement for EV Manufacturing & Testing (MIT collaboration) around 27-Sep worth up to $250,000.
Agency
Source Level 1 Agency
Department of Health and Human Services
Source Level 2 Agency
FDA
Contacts
Potential Bidders and Partners
Similar Active Opportunities
Additional Detail
Date Published
11/6/26
Date Modified
11/7/26
Additional Notes
Program Office: 75F401; Contracting Office: 75F402